Cas:55481-88-4 mollugin manufacturer & supplier

Chemical Name:mollugin

CAS.NO:55481-88-4

Synonyms:Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate;5-Carbomethoxy-6-hydroxy-2,2-dimethyl-2H-naphtho<1,2-b>-pyran;2H-Naphtho[1,2-b]pyran-5-carboxylic acid, 6-hydroxy-2,2-dimethyl-, methyl ester;Rubimaillin;Mollugin/rubiMaillin;6-hydroxy-2,2-dimethyl-,methylester;mollugin

Molecular Formula:C₁₇H₁₆O₄

Molecular Weight:284.306

HS Code:29329990

Physical and Chemical Properties:

Melting point:132-134ºC

Boiling point:453.2±45.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.619

PSA:55.76000

Exact Mass:284.104858

LogP:5.16

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,mollugin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Rubimaillin Use and application,1,2-b&gt technical grade,usp/ep/jp grade.

Related News: A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. mollugin manufacturer A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. mollugin supplier Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. mollugin vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. mollugin factory Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads.